Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Intravenous chemotherapy compounding errors in a follow-up pan-Canadian observational study.

Gilbert RE, Kozak MC, Dobish RB, et al. Intravenous Chemotherapy Compounding Errors in a Follow-Up Pan-Canadian Observational Study. J Oncol Pract. 2018;14(5):e295-e303. doi:10.1200/JOP.17.00007.

Save
Print
May 9, 2018
Gilbert RE, Kozak MC, Dobish RB, et al. J Oncol Pract. 2018;14(5):e295-e303.
View more articles from the same authors.

This direction observation study identified multiple vulnerabilities in the chemotherapy medication compounding process. The authors emphasize the complexity of this entirely manual process and suggest that current practices carry significant risk for patient harm.

Save
Print
Cite
Citation

Gilbert RE, Kozak MC, Dobish RB, et al. Intravenous Chemotherapy Compounding Errors in a Follow-Up Pan-Canadian Observational Study. J Oncol Pract. 2018;14(5):e295-e303. doi:10.1200/JOP.17.00007.

Related Resources From the Same Author(s)
Related Resources